ATLASATLAS fair value
CN¥20.54
Above fair value · 11% premium
Range: CN¥14–CN¥25Fair valuePrice
Shanghai Fosun Pharmaceutical (600196.SHG)
Shanghai Fosun Pharmaceutical stock price today, ATLAS forecast and fair value
Healthcare · Drug Manufacturers - Specialty & Generic · Shanghai Stock Exchange · China
CN¥22.75▼ -3.03%
Prices as of Oct 27, 2026 · CNY
Chance of rising in 1 month
52%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on Shanghai Fosun Pharmaceutical in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On Shanghai Fosun Pharmaceutical
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS estimates Shanghai Fosun Pharmaceutical's fair value at about CN¥20.54 per share (reasonable range: CN¥13.61 to CN¥24.92). At CN¥22.75, the stock trades 11% above it.
It is calculated with a blend of a discounted cash-flow model and peer valuation multiples. Confidence in the estimate is medium. It is an estimate, not a promise: if the company's results change, so does its fair value.
ATLAS's model gives Shanghai Fosun Pharmaceutical a 52% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between CN¥21.76 and CN¥23.91; in 9 out of 10, between CN¥20.02 and CN¥26.00. Estimated annual volatility is 28%.
Price, last 12 months (weekly close)
Key numbers
- Market cap
- CN¥61.9B
- Market cap (USD)
- $9.3B
- P/E ratio
- 17.9
- Dividend yield
- 1.70%
- 52-week high
- CN¥29.68
- 52-week low
- CN¥20.85
- Revenue (12 months)
- CN¥42.6B
- Gross margin
- 50.6%
- Operating margin
- 4.9%
- Net margin
- 8.0%
- Beta
- 0.38
What this means
These are two different questions: fair value looks at the business (what it is worth given what it earns) and the odds look at the price over the next month. Shanghai Fosun Pharmaceutical sits above fair value and its odds of rising over a month are close to a coin flip. An expensive stock can keep climbing and a cheap one can keep falling, which is why ATLAS shows the two readings separately.
Over the last 52 weeks 600196.SHG has traded between CN¥20.85 and CN¥29.68. Today it is 23.4% below that high and 9% above its low.
On the business: net margin is 8.0%; it trades at 17.9 times earnings.
Its beta is 0.38: it tends to move less than the market.
About the company
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. engages in the pharmaceutical business in Mainland China and internationally. It operates through five segments: Pharmaceuticals, Medical Devices and Medical Diagnosis, Medical Services, Medical Distribution and Retail, and Others.
Want to see everything about Shanghai Fosun Pharmaceutical?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What is Shanghai Fosun Pharmaceutical (600196.SHG) fair value?
About CN¥20.54 per share according to ATLAS (reasonable range: CN¥13.61 to CN¥24.92). With the stock at CN¥22.75, it is 11% above it.
What is the chance 600196.SHG goes up next month?
52%: close to a coin flip. In half of the simulated outcomes, 600196.SHG ends the month between CN¥21.76 and CN¥23.91.
How big is Shanghai Fosun Pharmaceutical and what is its P/E ratio?
Shanghai Fosun Pharmaceutical's market capitalization is CN¥61.9B. Its price-to-earnings (P/E) ratio is 17.9: you pay CN¥17.9 for each CN¥1.00 of yearly earnings.
Does Shanghai Fosun Pharmaceutical pay a dividend?
Yes. 600196.SHG's current dividend yield is 1.70% at today's price (CN¥22.75).
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer